Education
About Us
Working with TipRanks
Follow Us
Yanina Grant-Huerta Insider Profile
4 Followers
Yanina Grant-Huerta, Chief Accounting Officer at Atara Biotherapeutics, holds 37.07K shares in Atara Biotherapeutics (Ticker: ATRA). Most recently, Yanina Grant-Huerta Sold $2,218 shares of Atara Biotherapeutics on May 20, 2025 for an estimated value of 14.99K.
Yanina Grant-Huerta has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Yanina Grant-Huerta's holdings
Insider Roles
Chief Accounting Officer
Roles that Yanina Grant-Huerta holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Yanina Grant-Huerta
Yanina Grant-Huerta's Trading History
List of latest transactions for each holding click on a transaction to see Yanina Grant-Huerta's performance on stock
You May Also Like
Yanina Grant-Huerta insider profile FAQ
What is the percentage of profitable transactions made by Yanina Grant-Huerta?
The percentage of profitable transactions made by Yanina Grant-Huerta is ―.
What is the average return per transaction made by Yanina Grant-Huerta?
The average return per transaction made by Yanina Grant-Huerta is ―.
What stocks does Yanina Grant-Huerta hold?
Yanina Grant-Huerta holds: ATRA stocks.
What was Yanina Grant-Huerta’s latest transaction?
Yanina Grant-Huerta latest transaction was an Informative Sell of $14.99K.
What was Yanina Grant-Huerta's most profitable transaction?
Yanina Grant-Huerta’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Yanina Grant-Huerta's role in Atara Biotherapeutics?
Yanina Grant-Huerta's role in Atara Biotherapeutics is Chief Accounting Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.